Skip to main content
. 2013 Aug 9;472(5):1384–1393. doi: 10.1007/s11999-013-3192-3

Fig. 2.

Fig. 2

This survival analysis curve describes the effect of mode of administration on time to discharge readiness. High concentration group, infusion of ropivacaine 0.2%; low concentration group, infusion of ropivacaine 0.1%; and placebo infusion group, infusion of normal saline 0.9%.